Nurix Therapeutics, Inc.
NRIX
42 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Jul 2 8:28 PM | CHRISTINE RING | Proposed Sale | 11,008 | $23.91 | $263.2K | — | View → |
| Jun 25, 2026 | Jun 25 10:49 PM | Gwenn HansenChief Scientific Officer | Sale | 5,394 | $20.00 | $107.9K | 115,005(D) | View → |
| Jun 25, 2026 | Jun 25 10:38 PM | Christine RingChief Legal Officer | Sale | 28,935 | $20.06 | $580.5K | 13,579(D) | View → |
| Jun 25, 2026 | Jun 25 8:24 PM | CHRISTINE RING | Proposed Sale | 28,935 | $19.30 | $558.4K | — | View → |
| Jun 25, 2026 | Jun 25 8:24 PM | GWENN M HANSEN | Proposed Sale | 5,394 | $19.30 | $104.1K | — | View → |
| Jun 2, 2026 | Jun 2 11:14 PM | Christine RingChief Legal Officer | Sale | 8,148 | $16.60 | $135.3K | 13,579(D) | View → |
| Jun 2, 2026 | Jun 2 8:34 PM | CHRISTINE RING | Proposed Sale | 8,148 | $17.39 | $141.7K | — | View → |
| May 5, 2026 | May 5 11:53 PM | Houte Hans VanChief Financial Officer | Sale | 14,055 | $16.60 | $233.3K | 37,592(D) | View → |
| May 5, 2026 | May 5 8:28 PM | JOHANNES VAN HOUTE | Proposed Sale | 14,055 | $16.93 | $238.0K | — | View → |
| May 4, 2026 | May 4 10:10 PM | Christine RingChief Legal Officer | Sale | 8,148 | $16.96 | $138.2K | 18,305(D) | View → |
| May 4, 2026 | May 4 8:27 PM | CHRISTINE RING | Proposed Sale | 8,148 | $16.81 | $137.0K | — | View → |
| May 1, 2026 | May 1 9:50 PM | Christine RingChief Legal Officer | Sale | 5,394 | $16.76 | $90.4K | 26,453(D) | View → |
| May 1, 2026 | May 1 8:49 PM | CHRISTINE RING | Proposed Sale | 5,394 | $16.70 | $90.1K | — | View → |
| Apr 30, 2026 | Apr 30 9:38 PM | Houte Hans VanChief Financial Officer | Sale | 2,388 | $16.65 | $39.7K | 51,647(D) | View → |
| Apr 30, 2026 | Apr 30 9:37 PM | Christine RingChief Legal Officer | Sale | 3,214 | $16.65 | $53.5K | 31,847(D) | View → |
| Apr 30, 2026 | Apr 30 9:35 PM | Gwenn HansenChief Scientific Officer | Sale | 3,214 | $16.65 | $53.5K | 120,399(D) | View → |
| Apr 2, 2026 | Apr 2 11:02 PM | Christine RingChief Legal Officer | Sale | 8,148 | $15.24 | $124.1K | 26,453(D) | View → |
| Apr 2, 2026 | Apr 2 8:25 PM | CHRISTINE RING | Proposed Sale | 8,148 | $15.48 | $126.1K | — | View → |
| Mar 2, 2026 | Mar 3 12:05 AM | Christine RingChief Legal Officer | Sale | 8,148 | $15.44 | $125.8K | 34,601(D) | View → |
| Mar 2, 2026 | Mar 2 9:33 PM | CHRISTINE RING | Proposed Sale | 8,148 | $15.97 | $130.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | May 15 9:37 PM | Julia P GregoryDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| Apr 30, 2026 | Apr 30 9:38 PM | Houte Hans VanChief Financial Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Apr 30, 2026 | Apr 30 9:37 PM | Christine RingChief Legal Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Apr 30, 2026 | Apr 30 9:35 PM | Gwenn HansenChief Scientific Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Feb 10, 2026 | Feb 10 11:09 PM | Houte Hans VanChief Financial Officer | Grant/Award | 136,625 | $16.45 | 42,875(D) | View → |
| Feb 10, 2026 | Feb 10 10:55 PM | Christine RingChief Legal Officer | Grant/Award | 136,625 | $16.45 | 42,875(D) | View → |
| Feb 10, 2026 | Feb 10 10:50 PM | Gwenn HansenChief Scientific Officer | Grant/Award | 136,625 | $16.45 | 42,875(D) | View → |
| Feb 10, 2026 | Feb 10 10:43 PM | SANDS ARTHUR TDirector, President, CEO | Grant/Award | 562,500 | $16.45 | 562,500(D) | View → |
| Feb 3, 2026 | Feb 4 2:12 AM | Gwenn HansenChief Scientific Officer | Option Exercise | 31,333 | $0.84 | 0(D) | View → |
| Jan 30, 2026 | Jan 31 1:39 AM | Houte Hans VanChief Financial Officer | Option Exercise | 11,496 | — | 25,725(D) | View → |
| Jan 30, 2026 | Jan 31 1:38 AM | Christine RingChief Legal Officer | Option Exercise | 10,534 | — | 25,725(D) | View → |
| Jan 30, 2026 | Jan 31 1:36 AM | Gwenn HansenChief Scientific Officer | Option Exercise | 11,816 | — | 25,725(D) | View → |
| Jan 20, 2026 | Jan 21 12:57 AM | Christine RingChief Legal Officer | Option Exercise | 3,760 | $1.86 | 8,643(D) | View → |
← Previous
Page 2 of 2